PAM50 test is now available to classify breast cancer subtypes

[News]

ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced the availability of a new laboratory developed test designed to classify breast cancer into clinically significant molecular subtypes that are important for the management of the disease.

More... (http://www.news-medical.net/news/20110118/PAM50-test-is-now-available-to-classify-breast-cancer-subtypes.aspx)